Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Lexicon Pharmaceuticals Inc News

    1,58 $ +2,60% +0,04 $
    In : 1,4776 € | 26.04.24 22:00:00 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A14SSK
    ISIN: US5288723027
    US-Symbol: LXRX
    Typ: Aktie

    Lexicon Pharmaceuticals Inc News

    13.03.24 - PR Newswire
    Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences?
    Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences? PR Newswire
    13.10.23 - PR Newswire
    Thinking about buying stock in Comtech Telecommunications, Tantech Holdings, MDxHealth, Lexicon Pharmaceuticals, or micromobility.com?
    Thinking about buying stock in Comtech Telecommunications, Tantech Holdings, MDxHealth, Lexicon Pharmaceuticals, or micromobility.com? PR Newswire
    10.10.23 - PR Newswire
    Thinking about buying stock in Immunic, BioXcel Therapeutics, Coherent Corp, Emx Royalty, or Lexicon Pharmaceuticals?
    Thinking about buying stock in Immunic, BioXcel Therapeutics, Coherent Corp, Emx Royalty, or Lexicon Pharmaceuticals? PR Newswire
    01.07.22 - PR Newswire
    Thinking about buying stock in Cytokinetics, Pure Storage, Revlon, Lexicon Pharmaceuticals, or Bloom Energy?
    Thinking about buying stock in Cytokinetics, Pure Storage, Revlon, Lexicon Pharmaceuticals, or Bloom Energy? PR Newswire
    26.03.22 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmaceuticals, Inc. - LXRX
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmaceuticals, Inc. - LXRX PR Newswire
    02.03.22 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmaceuticals, Inc. - LXRX
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmaceuticals, Inc. - LXRX PR Newswire
    31.12.21 - PR Newswire
    Thinking about buying stock in Assertio Holdings, Siyata Mobile, Insignia Systems, Energy Focus, or Lexicon Pharmaceuticals?
    Thinking about buying stock in Assertio Holdings, Siyata Mobile, Insignia Systems, Energy Focus, or Lexicon Pharmaceuticals? PR Newswire
    30.08.21 - PR Newswire
    Thinking about buying stock in Marqeta, Lexicon Pharmaceuticals, Kala Pharmaceuticals, Owlet, or New Oriental Education?
    Thinking about buying stock in Marqeta, Lexicon Pharmaceuticals, Kala Pharmaceuticals, Owlet, or New Oriental Education? PR Newswire
    30.07.21 - PR Newswire
    Thinking about buying stock in Lexicon Pharmaceuticals, Agile Therapeutics, Summit Wireless, Resonant, or Nokia?
    Thinking about buying stock in Lexicon Pharmaceuticals, Agile Therapeutics, Summit Wireless, Resonant, or Nokia? PR Newswire
    08.12.20 - PR Newswire
    Thinking about buying stock in Pfizer, Nio, Lexicon Pharmaceuticals, Oncolytics Biotech, or Boeing?
    Thinking about buying stock in Pfizer, Nio, Lexicon Pharmaceuticals, Oncolytics Biotech, or Boeing? PR Newswire
    03.08.20 - PR Newswire
    GTCR and TerSera Therapeutics Announce Acquisition of Xermelo
    GTCR and TerSera Therapeutics Announce Acquisition of Xermelo Acquisition Further Expands TerSera's Portfolio in Oncology PR Newswire
    21.07.20 - PR Newswire
    Thinking about buying stock in New Age Beverages, Lexicon Pharmaceuticals, Miragen Therapeutics, Opko Health, or Niu Technologies?
    Thinking about buying stock in New Age Beverages, Lexicon Pharmaceuticals, Miragen Therapeutics, Opko Health, or Niu Technologies? PR Newswire
    26.02.19 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - LXRX
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming ...
    14.02.19 - PR Newswire
    Lifshitz & Miller LLP Announces Investigation of Arlo Technologies, Inc., Alkermes Public Limited Company, Lexicon Pharmaceuticals, Inc., BSB Bancorp, Inc., Markel Corporation, Natural Health Trends Corp., and Nova Lifestyle, Inc.
    Lifshitz & Miller LLP Announces Investigation of Arlo Technologies, Inc., Alkermes Public Limited Company, Lexicon Pharmaceuticals, Inc., BSB Bancorp, Inc., Markel Corporation, ...
    30.01.19 - PR Newswire
    LEXICON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lexicon Pharmaceuticals, Inc. To Contact The Firm
    LEXICON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lexicon Pharmaceuticals, Inc. To Contact The Firm ...
    22.01.19 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmaceuticals, Inc. - LXRX
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmaceuticals, Inc. - LXRX PR Newswire
    26.07.18 - PR Newswire
    New Insights Revealed in National Survey Show More Advances Are Needed for the Type 1 Diabetes Community
    New Insights Revealed in National Survey Show More Advances Are Needed for the Type 1 Diabetes Community Endocrinologists and Adults with Type 1 Diabetes Struggle to Keep ...
    22.05.18 - PR Newswire
    FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes
    FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes PR Newswire
    08.11.17 - PR Newswire
    Lexicon Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides A Business Update
    Lexicon Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides A Business Update XERMELO® (telotristat ethyl) U.S. Quarterly Net Sales Reach $5.3 Million ...
    03.11.17 - PR Newswire
    Lexicon Pharmaceuticals To Host Third Quarter 2017 Financial Results Conference Call And Webcast On November 8, 2017
    Lexicon Pharmaceuticals To Host Third Quarter 2017 Financial Results Conference Call And Webcast On November 8, 2017 PR Newswire

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »